| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/16/2005 | US20050130138 Immune-related proteins and the regulation of the same |
| 06/16/2005 | US20050130137 Vitronectin adhesion receptor for use in identifying modulators for treatment and prevention of cell proliferative and blood disorders |
| 06/16/2005 | US20050130135 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 06/16/2005 | US20050130132 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 06/16/2005 | US20050130131 Contacting macrophages in vitro with composition comprising hepatitis c viral particles, culture cells, incubate with non-macrophage cells, culture, recover viral particles; viricides and rational drug design |
| 06/16/2005 | US20050130130 Killer cell activatory receptor ligand for use in diagnosis, prevention and treatment of infection, cell proliferative, autoimmune and arthritic disorders |
| 06/16/2005 | US20050130129 Targeting gene transfer vectors to certain cell types by pseudotyping with viral glycoprotein |
| 06/16/2005 | US20050130128 Methods for detecting NEBR1 expression in a biological sample by contacting a sample with the labeled antibody; inhibits HIV replication in host cells |
| 06/16/2005 | US20050130127 Coronavirus-like particles comprising functionally deleted genomes |
| 06/16/2005 | US20050130126 AbiZ phage resistance gene |
| 06/16/2005 | US20050130125 End of aids for general virology, based on profound science as protein foldings: safe vaccines, universal antimicrobial means, mad cow end |
| 06/16/2005 | US20050129717 Novel uses |
| 06/16/2005 | US20050129715 Methods and compositions for immunotherapy of cancer |
| 06/16/2005 | US20050129713 For use in vaccine |
| 06/16/2005 | US20050129705 hepatitis C virus; for activating cytotoxic t lymphocytes in presence of major histomcompatibility complex |
| 06/16/2005 | US20050129704 An immunogenic complex that includes plant cells transformed with a chimeric gene containing a nucleotide sequence adapted for protein expression in plants and an RSV coding sequence that encodes an antigenic protein of RSV |
| 06/16/2005 | US20050129703 identifying T cells in a sample that become activated in the presence of a vaccinia or variola virus using immunogenic mutant or fragment of peptide 165 as a CD8 T cell epitope |
| 06/16/2005 | US20050129700 comprises antibodies against Smallpox Inhibitor of Complement Enzyme (SPICE) or Vaccinia Virus Complement Control Protein (VCP); dna vaccines |
| 06/16/2005 | US20050129698 Polypeptides (MBP1) capable of interacting with oncogenic mutants of the p53 protein |
| 06/16/2005 | US20050129692 Methods of expressing integrin beta6 subunits |
| 06/16/2005 | US20050129688 Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms thereof, pharmaceutical compositions containing, and use thereof as immunosuppressants |
| 06/16/2005 | US20050129685 Use of IL-1 blockers to prevent corneal inflammation and neovascularization |
| 06/16/2005 | US20050129683 Human testis expressed patched like protein |
| 06/16/2005 | US20050129677 Altering the degree of internalization of the toxin; preventing or treating botulinum toxin intoxication; treating metabolic disorders, muscular disorders, nervous system disorders, and/or pain conditions |
| 06/16/2005 | US20050129676 Compounds and methods for modulating functions of classical cadherins |
| 06/16/2005 | US20050129670 Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor |
| 06/16/2005 | US20050129661 For gene therapy; cochleates containing rep proteins and DNA with inverted terminal repeats (ITRs) for use as a vector for efficient delivery of genes |
| 06/16/2005 | US20050129657 Interferon-alpha induced gene |
| 06/16/2005 | US20050129625 Aerosolizing dry powder of interleukin-4 receptor with carbohydrage, lipid, buffer, peptide, protein, Group II metal, or oligopeptide excipient; small aerodynamic particle size; dispersion into gas stream to make inhalant |
| 06/16/2005 | US20050129617 Contacting a T lymphocyte from the patient with a diagnostic epitope of an amino acid string including hydrophilic amino acids and one of Leucine, Methionine, Isoleucine, Phenylalanine, Alanine, Glycine, Valine, or Tryptophan |
| 06/16/2005 | DE10352433A1 Enzymatische Synthese, Modifikation und Abbau von Silicium(IV)-und anderer Metall(IV)-Verbindungen Enzymatic synthesis, modification and elimination of silicon (IV) -and other metal (IV) -compounds |
| 06/16/2005 | DE10351627A1 Modulation der Angiogenese durch Bartonella henselae Modulation of angiogenesis by Bartonella henselae |
| 06/16/2005 | CA2765442A1 Novel centromeric protein shugoshin |
| 06/16/2005 | CA2764400A1 Novel centromeric protein shugoshin |
| 06/16/2005 | CA2764298A1 Novel centromeric protein shugoshin |
| 06/16/2005 | CA2565173A1 Interleukin-11 fusion proteins |
| 06/16/2005 | CA2548582A1 Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis |
| 06/16/2005 | CA2548454A1 Medicament comprising recombinant antibody against chemokine receptor ccr4 |
| 06/16/2005 | CA2548381A1 Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target |
| 06/16/2005 | CA2548208A1 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof |
| 06/16/2005 | CA2548185A1 Expression systems using mammalian .beta.-actin promoter |
| 06/16/2005 | CA2548135A1 Synthetic hla binding peptide analogues and uses thereof |
| 06/16/2005 | CA2547885A1 Methods for obtaining gene tags |
| 06/16/2005 | CA2547655A1 Novel centromeric protein shugoshin |
| 06/16/2005 | CA2547537A1 Protein nmb0928 and use thereof in pharmaceutical formulations |
| 06/16/2005 | CA2547355A1 Animal models of pancreatic adenocarcinoma and uses therefor |
| 06/16/2005 | CA2547317A1 Protein nmb1125 and use thereof in pharmaceutical formulations |
| 06/16/2005 | CA2546942A1 A method for isolating a self-renewing, multipotent slow-cycling cell |
| 06/16/2005 | CA2546796A1 Peptide hormones zalpha48 and zsig97 |
| 06/16/2005 | CA2546789A1 Gag binding proteins |
| 06/16/2005 | CA2546680A1 Promoters for expression in modified vaccinia virus ankara |
| 06/16/2005 | CA2545581A1 Clp-protease as target for herbicides |
| 06/16/2005 | CA2545474A1 Nanofiltration of factor vii solutions to remove virus |
| 06/16/2005 | CA2545408A1 Selective neuropeptide y2 receptor agonists |
| 06/16/2005 | CA2544888A1 Rgd targeting moiety its production and use |
| 06/16/2005 | CA2544409A1 Use of il-6-type cytokines for maturation of oocytes |
| 06/16/2005 | CA2491241A1 Process for cross-linking proteins using a ketose with three to five carbon atoms |
| 06/15/2005 | EP1541689A2 Hybrid proteins which form heterodimers |
| 06/15/2005 | EP1541687A1 The rice restorer gene to the rice bt type cytoplasmic male sterility |
| 06/15/2005 | EP1541685A1 Factor participating in transcriptional regulation |
| 06/15/2005 | EP1541684A1 Smg-1-binding protein and method of screening substance controlling its activity |
| 06/15/2005 | EP1541683A1 ESTs and encoded human proteins |
| 06/15/2005 | EP1541682A2 Generation and selection of recombinant varied binding proteins |
| 06/15/2005 | EP1541679A1 Method of analyzing organelle-localized protein and materials for analysis |
| 06/15/2005 | EP1541677A1 Novel proteins and use thereof |
| 06/15/2005 | EP1541676A1 Antibodies to fragment F1+2 of prothrombin, their production and use |
| 06/15/2005 | EP1541634A1 Process for the preparation of micronised collagen, and its therapeutic applications |
| 06/15/2005 | EP1541589A1 Fused protein with the function of both hemolysis and anticoagulation and the use of it |
| 06/15/2005 | EP1541587A2 Method for down-regulating osteoprotegerin ligand activity |
| 06/15/2005 | EP1541586A1 Novel gene associated with rheumatoid arthritis |
| 06/15/2005 | EP1541167A1 Antiallergic agent |
| 06/15/2005 | EP1541135A1 Hollow nanoparticle having modified cysteine residue and drug with the use thereof |
| 06/15/2005 | EP1540559A2 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 06/15/2005 | EP1540333A2 Maxs as modifiers of the axin pathway and methods of use |
| 06/15/2005 | EP1540332A1 Methods of screening compounds for grk6 modulating activity |
| 06/15/2005 | EP1540324A2 Method and system for multi-stage isoelectric focussing |
| 06/15/2005 | EP1540016A2 Method for determining the allelic state of the 5'-end of the $g(a)s1-casein gene |
| 06/15/2005 | EP1540010A2 Use of biomarkers for detecting ovarian cancer |
| 06/15/2005 | EP1540008A2 Fluorescent proteins, nucleic acids encoding them and methods for making and using them |
| 06/15/2005 | EP1539996A1 Method of producing plants having enhanced transpiration efficiency and plants produced therefrom |
| 06/15/2005 | EP1539985A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/15/2005 | EP1539983A2 Methods for efficient production of mammalian recombinant proteins |
| 06/15/2005 | EP1539974A1 Orthopoxvirus vectors, genes and products thereof |
| 06/15/2005 | EP1539970A2 Seed-associated promoter sequences |
| 06/15/2005 | EP1539968A2 Plastid genetic engineering via somatic embryogenesis |
| 06/15/2005 | EP1539966A1 Protein production method |
| 06/15/2005 | EP1539965A1 Expression of the human igf-1 in transgenic plastids |
| 06/15/2005 | EP1539964A2 Collectin-complement activating protein chimeras |
| 06/15/2005 | EP1539963A2 Chimeric recombinant protein and in vitro diagnosis |
| 06/15/2005 | EP1539961A2 Improved transporters and their uses |
| 06/15/2005 | EP1539960A2 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 06/15/2005 | EP1539959A2 Ghrh analogues |
| 06/15/2005 | EP1539958A2 Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals |
| 06/15/2005 | EP1539957A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 06/15/2005 | EP1539956A2 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 06/15/2005 | EP1539955A2 G-protein coupled receptor polynucleotides and methods of use thereof |
| 06/15/2005 | EP1539952A1 Method for the expression of unknown environmental dna into adapted host cells |
| 06/15/2005 | EP1539950A1 Rational directed protein evolution using two-dimensional rational mutagenesis scanning |
| 06/15/2005 | EP1539949A2 Nucleic acid molecules from rice encoding rar1 disease resistance proteins and uses thereof |
| 06/15/2005 | EP1539943A2 Method for identifying mhc-presented peptide epitopes for t cells |